C. J. Kim

发表

The expression kinetics of CD137 in chronic hepatitis C patients treated with pegylated-interferon and ribavirin

N. Park, I. Jeong, S. Jung, 2012, Scandinavian journal of gastroenterology.

Efficacy and safety of tenofovir in nucleos(t)ide-naïve patients with genotype C chronic hepatitis B in real-life practice

N. Park, S. Jung, J. Shin, 2015, International Journal of Clinical Pharmacy.

Somatic Mutation of ARHI Gene in Hepatocellular Carcinomas

N. Park, S. Jung, J. Shin, 2015, Pathology & Oncology Research.

Mutational analysis of SATB1 gene in hepatocellular carcinomas

N. Park, S. Jung, J. Shin, 2013, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Tenofovir‐based rescue therapy for chronic hepatitis B patients who had failed treatment with lamivudine, adefovir, and entecavir

Eun Hye Kim, Byung Gyu Kim, N. Park, 2015, Journal of gastroenterology and hepatology.

Capsaicin suppresses the migration of cholangiocarcinoma cells by down-regulating matrix metalloproteinase-9 expression via the AMPK–NF-κB signaling pathway

I. Han, N. Park, Gong-Rak Lee, 2014, Clinical & Experimental Metastasis.

Efficacy of Tenofovir-based Rescue Therapy in Lamivudine-resistant Chronic Hepatitis B Patients With Failure of Lamivudine and Adefovir Combination.

Byung Gyu Kim, N. Park, I. Jeong, 2015, Clinical therapeutics.

Clinical usefulness of sequential hepatitis B virus DNA measurement (the roadmap concept) during adefovir treatment in lamivudine-resistant patients

N. Park, I. Jeong, S. Jung, 2009, Antiviral therapy.

HBV Dna Level at 24 Weeks is the Best Predictor of Virological Response to Adefovir Add-On Therapy in Patients with Lamivudine Resistance

Byung Gyu Kim, N. Park, I. Jeong, 2012, Antiviral therapy.

Polymorphisms of DNA repair genes in Korean hepatocellular carcinoma patients with chronic hepatitis B: possible implications on survival.

E. Shin, Y. Chung, N. Park, 2012, Journal of hepatology.

Clinical course of patients with insufficient viral suppression during entecavir therapy in genotype C chronic hepatitis B.

Byung Gyu Kim, N. Park, I. Jeong, 2013, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Prognostic impact of telomere maintenance gene polymorphisms on hepatocellular carcinoma patients with chronic hepatitis B

E. Shin, Y. Chung, N. Park, 2014, Hepatology.

Tonicity-responsive enhancer-binding protein promotes hepatocellular carcinogenesis, recurrence and metastasis

K. Myung, Jiyoung Park, N. Park, 2018, Gut.

Mutational analysis of FEN1 Gene in hepatocellular carcinomas

H. Cha, N. Park, S. Jung, 2014, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Capsaicin suppresses the migration of cholangiocarcinoma cells by down-regulating matrix metalloproteinase-9 expression via the AMPK–NF-κB signaling pathway

I. Han, N. Park, Soo Hwa Jang, 2014, Clinical & Experimental Metastasis.

Roads towards a new tailored therapy for hepatocellular carcinoma: diagnostic, therapeutic and prognostic implications of microRNAs

Y. Chung, N. Park, C. J. Kim, 2012, Liver international : official journal of the International Association for the Study of the Liver.

HBV Dna Level at 24 Weeks is the Best Predictor of Virological Response to Adefovir Add-On Therapy in Patients with Lamivudine Resistance

Byung Gyu Kim, N. Park, I. Jeong, 2012, Antiviral therapy.